annual total liabilities:
$465.07M-$22.39M(-4.59%)Summary
- As of today (September 15, 2025), SUPN annual total liabilities is $465.07 million, with the most recent change of -$22.39 million (-4.59%) on December 31, 2024.
- During the last 3 years, SUPN annual total liabilities has fallen by -$552.51 million (-54.30%).
- SUPN annual total liabilities is now -54.30% below its all-time high of $1.02 billion, reached on December 31, 2021.
Performance
SUPN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$318.50M+$1.92M(+0.61%)Summary
- As of today (September 15, 2025), SUPN quarterly total liabilities is $318.50 million, with the most recent change of +$1.92 million (+0.61%) on June 30, 2025.
- Over the past year, SUPN quarterly total liabilities has dropped by -$39.87 million (-11.13%).
- SUPN quarterly total liabilities is now -68.70% below its all-time high of $1.02 billion, reached on December 31, 2021.
Performance
SUPN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SUPN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.6% | -11.1% |
| 3 y3 years | -54.3% | -62.7% |
| 5 y5 years | -22.8% | -61.4% |
SUPN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.3% | at low | -66.5% | +0.6% |
| 5 y | 5-year | -54.3% | at low | -68.7% | +0.6% |
| alltime | all time | -54.3% | +1177.0% | -68.7% | +774.6% |
SUPN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $318.50M(+0.6%) |
| Mar 2025 | - | $316.58M(-31.9%) |
| Dec 2024 | $465.07M(-4.6%) | $465.07M(+38.6%) |
| Sep 2024 | - | $335.55M(-6.4%) |
| Jun 2024 | - | $358.38M(-4.4%) |
| Mar 2024 | - | $374.92M(-23.1%) |
| Dec 2023 | $487.46M(-48.8%) | $487.46M(+30.7%) |
| Sep 2023 | - | $372.97M(-0.1%) |
| Jun 2023 | - | $373.19M(-57.6%) |
| Mar 2023 | - | $879.66M(-7.5%) |
| Dec 2022 | $951.18M(-6.5%) | $951.18M(+13.2%) |
| Sep 2022 | - | $840.33M(-1.5%) |
| Jun 2022 | - | $853.54M(+5.2%) |
| Mar 2022 | - | $811.07M(-20.3%) |
| Dec 2021 | $1.02B(+20.8%) | $1.02B(+36.7%) |
| Sep 2021 | - | $744.57M(-5.4%) |
| Jun 2021 | - | $787.48M(+4.6%) |
| Mar 2021 | - | $753.00M(-10.6%) |
| Dec 2020 | $842.10M(+39.8%) | $842.10M(+5.1%) |
| Sep 2020 | - | $801.14M(-2.9%) |
| Jun 2020 | - | $825.05M(+43.1%) |
| Mar 2020 | - | $576.48M(-4.3%) |
| Dec 2019 | $602.14M(+8.3%) | $602.14M(+9.6%) |
| Sep 2019 | - | $549.65M(+1.6%) |
| Jun 2019 | - | $540.77M(-0.9%) |
| Mar 2019 | - | $545.43M(-1.9%) |
| Dec 2018 | $556.25M(+223.5%) | $556.25M(+11.1%) |
| Sep 2018 | - | $500.58M(+8.3%) |
| Jun 2018 | - | $462.31M(-2.3%) |
| Mar 2018 | - | $473.29M(+175.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $171.95M(+45.9%) | $171.95M(+28.5%) |
| Sep 2017 | - | $133.81M(+14.4%) |
| Jun 2017 | - | $116.97M(+0.7%) |
| Mar 2017 | - | $116.19M(-1.4%) |
| Dec 2016 | $117.81M(+17.1%) | $117.81M(+5.4%) |
| Sep 2016 | - | $111.75M(+3.1%) |
| Jun 2016 | - | $108.41M(+11.3%) |
| Mar 2016 | - | $97.36M(-3.2%) |
| Dec 2015 | $100.62M(+52.1%) | $100.62M(+75.5%) |
| Sep 2015 | - | $57.33M(-30.2%) |
| Jun 2015 | - | $82.19M(+8.6%) |
| Mar 2015 | - | $75.65M(+14.4%) |
| Dec 2014 | $66.15M(-14.7%) | $66.15M(+9.9%) |
| Sep 2014 | - | $60.21M(-1.0%) |
| Jun 2014 | - | $60.82M(-11.2%) |
| Mar 2014 | - | $68.51M(-11.6%) |
| Dec 2013 | $77.53M(+112.9%) | $77.53M(-30.3%) |
| Sep 2013 | - | $111.31M(+15.9%) |
| Jun 2013 | - | $96.08M(+154.3%) |
| Mar 2013 | - | $37.79M(+3.8%) |
| Dec 2012 | $36.42M(-17.8%) | $36.42M(-14.1%) |
| Sep 2012 | - | $42.38M(+0.9%) |
| Jun 2012 | - | $41.98M(-2.2%) |
| Mar 2012 | - | $42.93M(-3.1%) |
| Dec 2011 | $44.29M(-51.5%) | $44.29M(-57.8%) |
| Sep 2011 | - | $104.83M(+14.8%) |
| Dec 2010 | $91.33M(+6.1%) | $91.33M(-2.2%) |
| Sep 2010 | - | $93.42M(+8.6%) |
| Dec 2009 | $86.05M(+2.6%) | $86.06M |
| Dec 2008 | $83.88M | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of SUPN is $465.07M
What is the all time high annual total liabilities for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual total liabilities is $1.02B
What is Supernus Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, SUPN annual total liabilities has changed by -$22.39M (-4.59%)
What is Supernus Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of SUPN is $318.50M
What is the all time high quarterly total liabilities for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly total liabilities is $1.02B
What is Supernus Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, SUPN quarterly total liabilities has changed by -$39.87M (-11.13%)